Loading...

Loading...

Year in Review
Year in Review
By - Mon, 09/23/2019 - 10:14
While Mexico’s chronic disease epidemic continues unabated, new hurdles have arisen.

Featured content

Most popular

https://mexicobusiness.news/tag/ana-longoria
More Health
As R&D Costs Increase, the Industry Must Find Innovative Ways to Bring Them Down
As R&D Costs Increase, the Industry Must Find Innovative Ways to Bring Them Down
By - Thu, 09/19/2019 - 17:52
R&D investment in life sciences continues unabated, leading to record-level pipelines for new medications.However,smaller returns on investment in R&D and a wave of patent expirations may dampen the steady growth of the global pharmaceutical industry
Innovation: Key Driver for Growth and Competitiveness
Innovation: Key Driver for Growth and Competitiveness
By - Thu, 09/05/2019 - 13:49
Mexico Health Summit 2019: Innovation, Key Driver for Growth and Competitiveness panel highlights
New Payment Models Can Increase Access to Innovative Medications
New Payment Models Can Increase Access to Innovative Medications
By - Fri, 07/12/2019 - 18:23
Technological advances allow the discovery of new medications at a faster pace, Ana Longoria explains how Novartis adapts to this environment
Risk-Sharing Model in the Face of Health Budget Challenges
Risk-Sharing Model in the Face of Health Budget Challenges
By - Wed, 09/05/2018 - 12:24
Novartis is a multinational pharmaceutical company headquartered in Switzerland with presence in over 140 countries.